After A Year Of Pelvic Mesh Criticism, US FDA Calls Meeting To Discuss The Beleaguered Products
Executive Summary
Following a number of reports and a major documentary criticizing the use of surgical mesh in transvaginal surgeries, regulators are calling on an expert panel and other stakeholders to provide recommendations on their safety and effectiveness.
You may also be interested in...
FDA Wants Feedback On How To Properly Label Devices With Risky Materials
The US agency wants stakeholders to chime in on what information should be included in product labels to notify patients about potential side-effects of medical device materials, without being too burdensome for manufacturers.
US Medtech Lobbyists Say They're Not Worried About Political Backlash From 'Implant Files'
The International Consortium of Investigative Journalists started publishing the findings of its "Implant Files" investigation last month, but the two main industry groups in the US have not picked up any significant political backlash resulting from the reporting so far.
FDA Looks To Lead World In Post-Market Device Surveillance With Safety Plan, Investments
US FDA Nov. 20 announced plans for a broad series of updates to its Medical Device Safety Action Plan for the next several months, with the goal that FDA "is consistently first among the world’s regulatory agencies to identify and act upon safety signals related to medical devices.